Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara J Buhrlage

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Cell Chemical Biology|February 23, 2019
Discovery of a First-In-Class Covalent Allosteric Inhibitor of SUMO E1 Activating EnzymeRobert S Magin, Laura M Doherty, Sara J Buhrlage
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|April 30, 2023
Proteomic approaches to study ubiquitinomicsIndrajit Sahu, He Zhu, Sara J Buhrlage, et al.
STAR Protocols|November 1, 2021
Identification of deubiquitinase inhibitors via high-throughput screening using a fluorogenic ubiquitin-rhodamine assayAnthony C Varca, Dominick Casalena, Douglas Auld, et al.
Chemical Society Reviews|June 18, 2021
Chemoproteomic methods for covalent drug discoveryWai Cheung Chan, Shabnam Sharifzadeh, Sara J Buhrlage, et al.
Expert Opinion on Therapeutic Patents|November 7, 2012
Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 - 2011)Xianming Deng, Hwan Geun Choi, Sara J Buhrlage, et al.
Molecular Cell|April 22, 2022
DUB to the rescueWei Pin Teh, He Zhu, Jarrod A Marto, et al.
Journal of the American Chemical Society|September 8, 2005
Stereochemical promiscuity in artificial transcriptional activatorsSara J Buhrlage, Brian B Brennan, Aaron R Minter, et al.
Bioorganic Chemistry|February 7, 2025
Deubiquitinase processing of a non-natural linkage of ubiquitinated-PTENReina Iwase, Isabella Jaen Maisonet, Kwangwoon Lee, et al.
Leukemia|January 25, 2021
Targeting ubiquitin-specific protease-7 in plasmacytoid dendritic cells triggers anti-myeloma immunityArghya Ray, Ting Du, Yan Song, et al.
Journal of Medicinal Chemistry|November 5, 2019
Advances in Discovering Deubiquitinating Enzyme (DUB) InhibitorsNathan J Schauer, Robert S Magin, Xiaoxi Liu, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Cell Chemical Biology|February 23, 2019
Discovery of a First-In-Class Covalent Allosteric Inhibitor of SUMO E1 Activating EnzymeRobert S Magin, Laura M Doherty, Sara J Buhrlage
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|April 30, 2023
Proteomic approaches to study ubiquitinomicsIndrajit Sahu, He Zhu, Sara J Buhrlage, et al.
STAR Protocols|November 1, 2021
Identification of deubiquitinase inhibitors via high-throughput screening using a fluorogenic ubiquitin-rhodamine assayAnthony C Varca, Dominick Casalena, Douglas Auld, et al.
Chemical Society Reviews|June 18, 2021
Chemoproteomic methods for covalent drug discoveryWai Cheung Chan, Shabnam Sharifzadeh, Sara J Buhrlage, et al.
Expert Opinion on Therapeutic Patents|November 7, 2012
Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 - 2011)Xianming Deng, Hwan Geun Choi, Sara J Buhrlage, et al.
Molecular Cell|April 22, 2022
DUB to the rescueWei Pin Teh, He Zhu, Jarrod A Marto, et al.
Journal of the American Chemical Society|September 8, 2005
Stereochemical promiscuity in artificial transcriptional activatorsSara J Buhrlage, Brian B Brennan, Aaron R Minter, et al.
Bioorganic Chemistry|February 7, 2025
Deubiquitinase processing of a non-natural linkage of ubiquitinated-PTENReina Iwase, Isabella Jaen Maisonet, Kwangwoon Lee, et al.
Leukemia|January 25, 2021
Targeting ubiquitin-specific protease-7 in plasmacytoid dendritic cells triggers anti-myeloma immunityArghya Ray, Ting Du, Yan Song, et al.
Journal of Medicinal Chemistry|November 5, 2019
Advances in Discovering Deubiquitinating Enzyme (DUB) InhibitorsNathan J Schauer, Robert S Magin, Xiaoxi Liu, et al.
Pageof 8